| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 242.89B | 251.18B | 261.12B | 227.53B | 241.26B | 183.01B |
| Gross Profit | 76.41B | 79.86B | 80.66B | 67.16B | 73.74B | 53.76B |
| EBITDA | 33.94B | 38.78B | 39.20B | 29.70B | 38.65B | 30.44B |
| Net Income | 14.62B | 16.69B | 20.23B | 14.17B | 20.21B | 14.83B |
Balance Sheet | ||||||
| Total Assets | 371.94B | 375.06B | 388.65B | 353.47B | 354.30B | 292.76B |
| Cash, Cash Equivalents and Short-Term Investments | 98.13B | 105.95B | 96.33B | 98.40B | 118.04B | 91.55B |
| Total Debt | 45.57B | 46.60B | 50.69B | 45.89B | 42.77B | 42.53B |
| Total Liabilities | 147.49B | 143.98B | 160.93B | 148.62B | 157.82B | 119.06B |
| Stockholders Equity | 217.85B | 223.47B | 220.43B | 198.21B | 188.98B | 166.90B |
Cash Flow | ||||||
| Free Cash Flow | 18.41B | 23.46B | -2.72B | -15.30B | 26.59B | 18.37B |
| Operating Cash Flow | 29.16B | 34.81B | 17.16B | 1.01B | 33.93B | 25.52B |
| Investing Cash Flow | -11.59B | -10.80B | -19.52B | -15.67B | -7.43B | -6.92B |
| Financing Cash Flow | -14.79B | -14.21B | -2.78B | -5.44B | -6.45B | -16.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥280.84B | 24.18 | ― | 1.49% | 18.20% | 28.13% | |
74 Outperform | ¥517.07B | 35.37 | 4.19% | 2.25% | 3.97% | -41.76% | |
73 Outperform | ¥372.57B | 25.49 | 6.61% | 2.35% | -9.06% | -35.95% | |
68 Neutral | $571.50B | 18.95 | 8.09% | 2.85% | 11.18% | -0.75% | |
65 Neutral | ¥262.65B | 14.95 | ― | 2.04% | -0.69% | -29.88% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥789.88B | 27.59 | 3.60% | 2.62% | 3.51% | ― |
ULVAC, Inc. reported a significant decline in its consolidated financial results for the first quarter ended September 30, 2025, with net sales dropping by 13.6% and operating profit plummeting by 60.4% compared to the previous year. Despite the downturn, the company maintains its forecast for the fiscal year ending June 30, 2026, indicating a slight decrease in net sales but an expected increase in profit attributable to owners of the parent, suggesting potential recovery and resilience in its operations.
The most recent analyst rating on (JP:6728) stock is a Buy with a Yen7680.00 price target. To see the full list of analyst forecasts on ULVAC stock, see the JP:6728 Stock Forecast page.